Cancer - VAI

February 3, 2023 Damon Runyon Fellowship sets new tempo for VAI cancer researcher’s career

The cello … or cancer research? There was a time when Dr. McLane Watson walked a tightrope, trying to decide between the two. While music…

January 31, 2023 Study reveals drivers of metastatic breast cancer

Cancers that metastasize, or spread from their original site to new areas of the body, are particularly challenging to treat. This is especially true in…

January 26, 2023 Van Andel Institute postdoctoral fellow Dr. McLane Watson awarded prestigious Damon Runyon Fellowship

GRAND RAPIDS, Mich. (Jan. 26, 2023) — Van Andel Institute postdoctoral fellow McLane Watson, Ph.D., has been named a Damon Runyon Fellow by the…

January 18, 2023 New model offers powerful tool for studying endometrial cancer

GRAND RAPIDS, MICH. (Jan. 18, 2023) — A new laboratory model will better enable scientists to study the development…

December 22, 2022 Research in review: A year of growth, discovery and gratitude

As we wrap up another year, Van Andel Institute’s commitment to discovery remains strong. More than 26 years ago, the Institute was founded with the…

December 14, 2022 Did you miss our 2022 Public Lecture Series? We have you covered.

How does cancer start, and can a tiny fish help cure it? What roles do random chance and metabolism play in health and disease? How…

November 1, 2022 Combining two cancer medications may increase survival in relapsed myelodysplastic syndrome, lays groundwork for future cancer therapies

GRAND RAPIDS, Mich. (Nov. 1, 2022) — A pair of cancer medications that act as a one-two punch against malignant cells demonstrated increased survival in…

September 15, 2022 Van Andel Institute awarded $7.9 million to continue role as Cancer Moonshot^SM Biobank Biorepository

GRAND RAPIDS, Mich. (Sept. 15, 2022) — Van Andel Institute’s Biorepository has been awarded a $7.9 million, five-year contract from the National Cancer Institute…